Zai Lab (ZLAB) EBIT (2020 - 2025)
Zai Lab (ZLAB) has disclosed EBIT for 6 consecutive years, with -$69.4 million as the latest value for Q4 2025.
- Quarterly EBIT fell 2.23% to -$69.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$229.4 million through Dec 2025, up 18.67% year-over-year, with the annual reading at -$229.4 million for FY2025, 18.67% up from the prior year.
- EBIT hit -$69.4 million in Q4 2025 for Zai Lab, down from -$48.8 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$48.8 million in Q3 2025 to a low of -$227.1 million in Q1 2021.
- Historically, EBIT has averaged -$99.1 million across 5 years, with a median of -$81.5 million in 2021.
- Biggest five-year swings in EBIT: crashed 390.25% in 2021 and later skyrocketed 64.88% in 2022.
- Year by year, EBIT stood at -$219.2 million in 2021, then surged by 55.61% to -$97.3 million in 2022, then decreased by 27.43% to -$124.0 million in 2023, then skyrocketed by 45.24% to -$67.9 million in 2024, then fell by 2.23% to -$69.4 million in 2025.
- Business Quant data shows EBIT for ZLAB at -$69.4 million in Q4 2025, -$48.8 million in Q3 2025, and -$54.9 million in Q2 2025.